These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26933845)

  • 1. Pharmaceutical Policy Reform--Balancing Affordability with Incentives for Innovation.
    Conti RM; Rosenthal MB
    N Engl J Med; 2016 Feb; 374(8):703-6. PubMed ID: 26933845
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicare and drug pricing.
    Iglehart JK
    N Engl J Med; 2003 Apr; 348(16):1590-7. PubMed ID: 12700381
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescription-drug prices.
    Frank RG
    N Engl J Med; 2004 Sep; 351(14):1375-7. PubMed ID: 15459294
    [No Abstract]   [Full Text] [Related]  

  • 4. Can price and regulatory controls replace free market competition in the drug industry?
    Buc NL; Levitt GM
    Healthspan; 1993 Nov; 10(10):30-2. PubMed ID: 10130839
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicare and prescription drugs.
    Iglehart JK
    N Engl J Med; 2001 Mar; 344(13):1010-5. PubMed ID: 11274630
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicare prescription drugs and reform: what the new law will mean to gastroenterologists and their patients.
    Fise T
    Am J Gastroenterol; 2004 May; 99(5):775-6. PubMed ID: 15128335
    [No Abstract]   [Full Text] [Related]  

  • 7. Health care reform in the United States: an opportunity for interventional radiologists.
    David Prologo J; Meltzer CC
    J Vasc Interv Radiol; 2014 Jun; 25(6):881-7. PubMed ID: 24788208
    [No Abstract]   [Full Text] [Related]  

  • 8. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
    Sarpatwari A; Avorn J; Kesselheim AS
    JAMA; 2018 Jun; 319(23):2373-2374. PubMed ID: 29800027
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicare reform's impact on long-term care.
    Stefanacci RG
    J Am Med Dir Assoc; 2004; 5(6):418-21. PubMed ID: 15530184
    [No Abstract]   [Full Text] [Related]  

  • 10. Rx: higher prices.
    Kosterlitz J
    Natl J (Wash); 1993 Feb; 25(7):396-9. PubMed ID: 10125572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling spending for prescription drugs.
    Altman SH; Parks-Thomas C
    N Engl J Med; 2002 Mar; 346(11):855-6. PubMed ID: 11893800
    [No Abstract]   [Full Text] [Related]  

  • 12. The need for health care reform.
    Mossinghoff GJ
    Health Syst Rev; 1994; 27(3):5-6. PubMed ID: 10134516
    [No Abstract]   [Full Text] [Related]  

  • 13. The Medicare prescription drug benefit.
    Ferman JH
    Healthc Exec; 2001; 16(4):58-9. PubMed ID: 11434135
    [No Abstract]   [Full Text] [Related]  

  • 14. Importing Prescription Drugs from Canada - Legal and Practical Problems with the Trump Administration's Proposal.
    Sachs RE; Bagley N
    N Engl J Med; 2020 May; 382(19):1777-1779. PubMed ID: 32374960
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceutical pricing: a review of proposals to improve access and affordability of prescription drugs.
    Tironi P
    Ann Health Law; 2010; 19(2):311-65, preceding i. PubMed ID: 21443147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paying for Prescription Drugs in the New Administration.
    Kesselheim AS; Hwang TJ; Avorn J
    JAMA; 2021 Mar; 325(9):819-820. PubMed ID: 33651097
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of drug regimen costs between the Medicare prescription discount program and other purchasing systems.
    Hayes JM; Walczak H; Prochazka A
    JAMA; 2005 Jul; 294(4):427-8. PubMed ID: 16046648
    [No Abstract]   [Full Text] [Related]  

  • 18. Who benefits from drug discounts? Drugmakers, hospitals battle over indigent-care program.
    Lee J
    Mod Healthc; 2013 Jul; 43(28):8-9. PubMed ID: 24044228
    [No Abstract]   [Full Text] [Related]  

  • 19. American pharmaceutical prices.
    Alagona P
    Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58. PubMed ID: 12592980
    [No Abstract]   [Full Text] [Related]  

  • 20. The cost of being excluded: impact of excluded medications under Medicare part D on nursing home residents.
    Stefanacci RG
    J Am Med Dir Assoc; 2005; 6(6):415-20. PubMed ID: 16286068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.